PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 5.80
+0.21 (3.76%)
Sep 18, 2026, 4:08 PM HKT
PegBio Market Cap
PegBio has a market cap or net worth of 2.27 billion as of September 18, 2026. Its market cap has decreased by -88.36% in one year.
Market Cap
2.27B
Enterprise Value
1.97B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.80
ChartMarket Cap Chart
Since May 27, 2025, PegBio's market cap has decreased from 4.46B to 2.27B, a decrease of -49.20%. That is a compound annual growth rate of -40.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.27B | -91.60% |
| Dec 31, 2025 | 26.99B | 504.83% |
| May 27, 2025 | 4.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioDlink International Company | 2.95B |
| Medtide | 2.92B |
| Laekna | 2.90B |
| Viva Biotech Holdings | 2.88B |
| Beijing Luzhu Biotechnology | 2.76B |
| Clover Biopharmaceuticals | 2.75B |
| Antengene Corporation | 2.21B |
| Frontage Holdings | 2.10B |